Brief: Cosmo Pharmaceuticals Says European Commission Approves Methylthioninium Chloride Cosmo
21/08/2020 06:02
Aug 21 (Reuters) - COSMO PHARMACEUTICALS NV COPN.S :
* EUROPEAN COMMISSION (EC) HAS APPROVED METHYLTHIONINIUM
CHLORIDE
COSMO, PROLONGED RELEASE TABLETS (METHYLENE BLUE MMX) FOR
VISUALIZATION OF COLORECTAL LESIONS DURING COLONOSCOPIES
Source text for Eikon: ID:nTEN0bz7qa
Further company coverage: COPN.S
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Cosmo NV
See all newsFocus: Beyond the Scale: Men turn to cosmetic clinics to complete weight-loss transformation
Ireland's Cosmo recurring revenue rises on winlevi growth, reaffirms FY guidance
Brief: Cosmo Pharmaceuticals H1 EPS EUR -0.279
Cosmo Pharma's male hair loss treatment shows sustained hair growth in year‑long study
Europe Research Roundup: Airbus ,Bechtle, Salzgitter